Cellosaurus logo
expasy logo

Cellosaurus RLUN005-2 (CVCL_E3NZ)

[Text version]
Cell line name RLUN005-2
Synonyms RLUN005; RLUN5-2; RLUN5; F_PDO_000027
Accession CVCL_E3NZ
Resource Identification Initiative To cite this cell line use: RLUN005-2 (RRID:CVCL_E3NZ)
Comments Group: Cancer organoid.
Part of: Fukushima Translational Research Project Patient-Derived Organoids (F-PDO) collection.
Population: Japanese.
Doubling time: 5 days (PubMed=31137590).
Omics: Genomics; Whole exome sequencing.
Omics: Transcriptomics; RNAseq.
Derived from site: In situ; Lung; UBERON=UBERON_0002048.
Disease Lung adenocarcinoma (NCIt: C3512)
Lung adenosquamous carcinoma (NCIt: C9133)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Male
Age at sampling 65Y
Category Cancer cell line
Web pages Info; FTRP; -; https://www.fmu.ac.jp/home/trc/en/contract-research-provision/f-pdo/
Publications

PubMed=31137590; DOI=10.3390/cells8050481; PMCID=PMC6562414
Nobuhiko Takahashi, Hirotaka Hoshi, Arisa Higa, Gen Hiyama, Hirosumi Tamura, Mayu Ogawa, Kosuke Takagi, Kazuhito Goda, Naoyuki Okabe, Satoshi Muto, Hiroyuki Suzuki ...Show all 14 authors... , Kenju Shimomura, Shinya Watanabe, Motoki Takagi; Show fewer authors
An in vitro system for evaluating molecular targeted drugs using lung patient-derived tumor organoids.
Cells 8:481.1-481.18(2019)

Cross-references
Cell line collections (Providers) CancerTools; 160936
Entry history
Entry creation19-Dec-2024
Last entry update14-Aug-2025
Version number3